Atwood & Palmer Inc Biogen Inc. Transaction History

Atwood & Palmer Inc

$1.45 Billion
Q3 2024

A detailed history of Atwood & Palmer Inc transactions in Biogen Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 5 shares of BIIB stock, worth $868. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 8 37.5%

Holding current value

$868

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$189.07 - $236.8 $567 - $710	-3 Reduced 37.5%	5 $0
Q1 2024 Apr 10, 2024	SELL	$212.02 - $267.71 $8.82 Million - $11.1 Million	-41,588 Reduced 99.98%	8 $1,000
Q4 2023 Jan 12, 2024	SELL	$222.59 - $267.94 $8,903 - $10,717	-40 Reduced 0.1%	41,596 $10.8 Million
Q3 2023 Oct 20, 2023	SELL	$253.3 - $285.89 $16,717 - $18,868	-66 Reduced 0.16%	41,636 $10.7 Million
Q2 2023 Jul 18, 2023	BUY	$275.25 - $318.06 $279,103 - $322,512	1,014 Added 2.49%	41,702 $11.9 Million
Q1 2023 Apr 21, 2023	BUY	$256.56 - $292.34 $13,854 - $15,786	54 Added 0.13%	40,688 $11.3 Million
Q4 2022 Jan 31, 2023	BUY	$252.44 - $306.72 $139,346 - $169,309	552 Added 1.38%	40,634 $11.3 Million
Q3 2022 Oct 12, 2022	BUY	$194.69 - $268.46 $93,061 - $128,323	478 Added 1.21%	40,082 $10.7 Million
Q2 2022 Jul 21, 2022	SELL	$187.54 - $223.02 $326,319 - $388,054	-1,740 Reduced 4.21%	39,604 $8.08 Million
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $22,671 - $28,564	117 Added 0.28%	41,344 $8.71 Million
Q4 2021 Jan 24, 2022	BUY	$223.92 - $287.77 $236,459 - $303,885	1,056 Added 2.63%	41,227 $9.89 Million
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $99,895 - $130,274	353 Added 0.89%	40,171 $11.4 Million
Q2 2021 Jul 26, 2021	BUY	$259.0 - $414.71 $121,730 - $194,913	470 Added 1.19%	39,818 $13.8 Million
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $131,921 - $154,554	543 Added 1.4%	39,348 $11 Million
Q4 2020 Feb 04, 2021	BUY	$236.26 - $355.63 $276,424 - $416,087	1,170 Added 3.11%	38,805 $9.5 Million
Q3 2020 Oct 28, 2020	BUY	$264.77 - $305.71 $45,010 - $51,970	170 Added 0.45%	37,635 $10.7 Million
Q2 2020 Jul 24, 2020	BUY	$258.66 - $342.55 $9.56 Million - $12.7 Million	36,965 Added 7393.0%	37,465 $10 Million
Q3 2019 Oct 21, 2019	SELL	$217.44 - $243.88 $43,488 - $48,776	-200 Reduced 28.57%	500 $116,000
Q2 2017 Aug 08, 2017	BUY	N/A	700	700 $190,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Account

Atwood & Palmer Inc Biogen Inc. Transaction History